The COVID-19 pandemic and epidemiology of the most common cancers  in the Subcarpathian and Silesian Provinces of Poland

Choręża, Piotr; Kruk, Wacław; Chudek, Jerzy; Owczarek, Aleksander

doi:10.26444/aaem/155304

Cited by 3 publications

(5 citation statements)

References 27 publications

(39 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…According to the register data, the most frequent cancers diagnosed in Poland in 2020 among women were: breast cancer (C50, according to the International Classification of Diseases 10th revision– ICD-10 classification), lung and bronchus cancer (C34), endometrial cancer (C54), and among men it were: prostate cancer (C61), lung and bronchus cancer (C34) and colon cancer (C18) [ 4 ]. Those findings correspond with our previous study concerning two Polish regions: the Silesian and Subcarpatian provinces [ 5 ].…”

Section: Introductionsupporting

confidence: 93%

“…In the current study, we have analyzed selected the most common cancers diagnosed in Poland in 2015–2021, based on the National Cancer Registry database and our previous study concerning two regions of southern Poland: the Silesian and Subcarpathian voivodeships [ 5 ]. It was colorectal cancer, lung and bronchus cancer, skin cancers (without melanoma), kidney cancer except for renal pelvis, and two gender-related cancers: breast cancer among women and prostate cancer among men.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

The epidemiology of the most frequent cancers in Poland in 2015–2021 and the impact of the COVID-19 pandemic on cancer incidence

Choręza,

Owczarek,

Kruk

et al. 2024

Arch Public Health

Self Cite

View full text Add to dashboard Cite

Background The late diagnosis, despite the improving availability and accessibility of diagnostic procedures during the last decade in Poland and cooperation between specialist cancer centres, remains an unsolved problem. Moreover, the accessibility to healthcare resources and diagnostic procedures has been drastically reduced because of the COVID-19 pandemic in 2019–2020. The study aimed to present the epidemiology of the most frequent cancers diagnosed in Poland as well as the impact of the COVID-19 pandemic on cancers’ incidence. Methods Depersonalized, epidemiological data was obtained from the National Health Fund of Poland. In this retrospective study, the epidemiological analysis was performed and divided into subregions, according to patients’ domicile. For each of the subregions, we have calculated the incidence rate per 100,000 standardized to the European Standard Population 2013. The time points of providing the first healthcare service were considered as the time of cancer diagnosis. Results In the 2015–2019 period, before the COVID-19 pandemic occurred, the nationwide incidence of analysed cancers remained stable or slightly decreased (as the lung cancer). Simultaneusly, during the same period the prevalence of the prostate cancer has increased and the large differences between subregions with the least and the highest incidence were observed. Subsequently, the incidences of all analyzed cancers decreased in 2020, compared to the period before the COVID-19 pandemic occurred. Then, in 2021 a disproportionate increase in cancers’ incidence rates was noted. Conclusions Our results show a significant decrease in the incidence rate of the most frequent cancers diagnosed in Poland in 2020 compared to 2019. Subsequently, in 2021 the increase of the incidence ratios was noted, most likely due to the gradual reduction of epidemic restrictions.

show abstract

Section: Introductionsupporting

confidence: 93%

Section: Discussionmentioning

confidence: 99%

The epidemiology of the most frequent cancers in Poland in 2015–2021 and the impact of the COVID-19 pandemic on cancer incidence

Choręza,

Owczarek,

Kruk

et al. 2024

Arch Public Health

Self Cite

View full text Add to dashboard Cite

show abstract

“…The analyses have focused on the most frequent cancers diagnosed in Poland in the 2015-2021 period, established based on the Polish National Cancer Registry 2021 rapport and our previous study concerning two Polish regions: the Silesian and Subcarpatian provinces [4]. It encloses malignant neoplasm of the colorectal -CRC (C18-C21 according to the ICD-10 classi cation), malignant neoplasm of bronchus and lung (C34), other malignant neoplasms of skin (C44), malignant neoplasm of kidney, except renal pelvis (C64) and malignant neoplasm of the breast (C50) among women or malignant neoplasm of the prostate (C61) in men.…”

Section: Methodsmentioning

confidence: 99%

“…In the current study, we have analyzed selected the most common cancers diagnosed in Poland in 2015-2021, based on the National Cancer Registry database and our previous study concerning two regions of southern Poland: the Silesian and Subcarpathian voivodeships [4]. It was colorectal cancer, lung and bronchus cancer, skin cancers (without melanoma), kidney cancer except for renal pelvis, and two gender-related cancers: breast cancer among women and prostate cancer among men.…”

Section: The Cancers Epidemiologymentioning

confidence: 99%

During a storm – the impact of the COVID-19 pandemic on the epidemiology of the most frequent cancers in Poland

Choręza,

Owczarek,

Kruk

et al. 2023

Preprint

Self Cite

View full text Add to dashboard Cite

Background The late diagnosis, despite improving availability and accessibility of diagnostic procedures during the last decade in Poland and cooperation between specialist cancer centres, remains an unsolved problem. A new coronavirus SARS-CoV2 causing the COVID-19 disease occurred in the end of 2019. In a few months, it has become the most fundamental problem for public health worldwide. The accessibility to healthcare resources and diagnostic procedures has been drastically reduced because of the COVID-19 pandemic in 2019–2020. The study was aimed to assess the effect of the COVID-19 pandemic and slow cancer burden on the healthcare system of the most frequent cancers in Poland in the period 2015–2021. Methods Depersonalized, epidemiological data was obtained from the National Health Found of Poland. The epidemiological analysis was performed and divided into subregions, according to patients’ domicile. For each of the subregions, we have calculated the incidence rate per 100,000 standardized to the ESP 2013. The time points of providing the first healthcare service were considered as the time of cancer diagnosis. Results Colorectal cancer has become the leading oncological problem in Poland in recent years and the long-term trend shows a significant increase in the SIR in 2021 compared to 2020. The SIR of the lung cancer decreased in 2015–2019 across the country as well as the burden of kidney cancer has decreased in most of the subregions. The breast and prostate cancers were the most frequent cancer diagnosed in Poland among women and men respectively. Such a situation has remained stable till 2020 when the COVID-19 pandemic has occurred. In 2020, compared to 2019 a visible reduction of SIR of the breast cancer in most of the subregions was found, especially in the eastern areas. In 2020 when the COVID-19 pandemic occurred, a visible reduction of the SIR of C61 in most of the subregions was found. Conclusions Our results show a significant decrease in the SIR of the most frequent cancers diagnosed in Poland in 2020 compared to 2019. Subsequently, the excessive increase in 2021 was found, the most likely due to the gradual reduction of epidemic restrictions.

show abstract

“…The COVID-19 pandemic affected over 663 million patients worldwide and resulted in at least 6 million deaths. Accurately assessing the number of infected patients and pandemicrelated deaths is challenging due to unreliable data during the initial stages of the pandemic when SARS-CoV-2 tests were not widely accessible [1][2][3]. Furthermore, in many countries, COVID-19 has become a subject of significant political debate, leading to unreliable reporting of pandemic-related morbidity and mortality [4][5][6].…”

Section: Introductionmentioning

confidence: 99%

Uncovering the effects of COVID-19 on in-hospital cardiac arrest – a living systematic review and meta-analysis

Bielski¹,

Pruc²,

Rafique³

et al. 2023

Ann Agric Environ Med.

View full text Add to dashboard Cite

Introduction and Objective.Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused a global pandemic and had a negative impact on the entire health care system. To understand the effect of COVID-19 on outcomes of in-hospital cardiac arrest (IHCA), a systematic review and meta-analysis of studies was designed to compare the pre-and intra-pandemic periods of adult patients who suffered cardiac arrest, and additionally by performing a sub-analysis related to COVID-19 positive vs. negative patients in the same group of patients. Materials and method. To evaluate the impact of COVID-19 on IHCA outcomes a systematic review and meta-analysis was performed. Pubmed (MEDLINE), Scopus, Embase, Web of Science, and Cochrane database were searched for articles published from 1 January 2020 -8 April 2023. Results. Return of spontaneous circulation events among IHCA patients in pre-COVID-19 and COVID-19 pandemic periods varied and amounted to 64.0% vs. 60.0%, respectively (OR=1.23; 95%CI: 1.19 to 1.26; p<0.001). Re-arrest occurrence was 4.5% vs. 4.9%, respectively (OR=1.24; 95%CI: 1.00 to 1.53; p=0.05). Survival to hospital discharge (SHD) was 25.1% compared to 20.9% for COVID-19 period (OR = 1.17; 95%CI: 0.96 to 1.41; p=0.12). During the COVID-19 period, SHD in COVID-19 positive patients was 14.0% compared to 25.9% for patients without 95%CI: 0.28 to 1.86; p=0.50). 30-day survival rate among COVID-19 positive vs. negative patients was 62.6% vs. 58.3%, respectively (OR =0.99; 95%CI: 0.23 to 4.24; p=0.99). Conclusions. Patients with SARS-CoV-2 infection had reduced rates of ROSC and SDH, as well as poorer neurologic outcomes and increased in hospital re-arrests during the COVID-19 period. However, the 30-day survival rate was similar in SARS-CoV-2 positive and negative patients.

show abstract

The COVID-19 pandemic and epidemiology of the most common cancers in the Subcarpathian and Silesian Provinces of Poland

Cited by 3 publications

References 27 publications

The epidemiology of the most frequent cancers in Poland in 2015–2021 and the impact of the COVID-19 pandemic on cancer incidence

The epidemiology of the most frequent cancers in Poland in 2015–2021 and the impact of the COVID-19 pandemic on cancer incidence

During a storm – the impact of the COVID-19 pandemic on the epidemiology of the most frequent cancers in Poland

Uncovering the effects of COVID-19 on in-hospital cardiac arrest – a living systematic review and meta-analysis

Contact Info

Product

Resources

About